MedPath

Studying the Effect of Cinnamon Oral Drop on Balance and Fear of Falling in Patients with Multiple Sclerosis (MS)

Phase 3
Conditions
Multiple Sclerosis.
Multiple Sclerosis
Registration Number
IRCT20190518043619N1
Lead Sponsor
Islamic Azad University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Patient should be with Multiple Sclerosis based on the diagnosis of the neurologist.
The patients’ age range should be between 18 and 50 years old.
The patients should be with relapsing-remitting MS.
The recorded disability measuring scale in the patient's medical record should be ranged from 5.1 to 6.
The patient should have permanent and regular treatment for 4 weeks before the intervention.
The patient should agree not to use any alternative medications for 7 days prior to the intervention until the end of the intervention.
The patients should not participate in regular exercises two months before the intervention.
The help-seeker should be interested in participating in this research.

Exclusion Criteria

Being pregnant or intending to be pregnant or lacate during the intervention.
Having liver and kidney dysfunction.
Having cardiovascular or infectional diseases.
Having allergy to cinnamon.
Having neurological diseases in addition to Multiple Sclerosis.
Having an experience of consuming alcohol or drug dependence.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Balance. Timepoint: At the beginning of the research, 1,2, and 3 months after using cinnamon orally. Method of measurement: Berg Balance Scale.
Secondary Outcome Measures
NameTimeMethod
Fear of Falling. Timepoint: at the beginning of the study, 1,2, and 3 months after the study. Method of measurement: effectiveness scale questionnaire in falling- international form.
© Copyright 2025. All Rights Reserved by MedPath